GM et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation 1999 Apr 6; 99(13):1666-70
57.Hak, Elisabeth et al. Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study. The Journal of Clinical Endocrinology & Metabolism Vol. 87, 2002, No. 8 3632-3639
58.Boyanov MA et al. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003 Mar;6(1):1-7.
59.Vakkat Muraleedharan and T. Hugh Jones. “Review: Testosterone and the metabolic syndrome,” Therapeutic Advances in Endocrinology and Metabolism 2010 Oct;1(5):207-23.
60.Bhasin S. et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997 Feb; 82(2):407-13.
61.Mudali S, Dobs AS. Effects of testosterone on body composition of the aging male. Mech Ageing Dev. 2004 Apr; 125(4):297-304
62.LeBlanc ES, Wang PY, Janowsky JS, Neiss MB, Fink HA, Yaffe K, Marshall LM, Lapidus JA, Stefanick ML, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group. Association between sex steroids and cognition in elderly men. Clin Endocrinol (Oxf). 2010 Mar;72(3):393-403.
63.Ekaterina L. Kovacheva, Amiya P. Sinha Hikim, Ruoqing Shen, Indranil Sinha, Indrani Sinha-Hikim. “ Testosterone Supplementation Reverses Sarcopenia in Aging through Regulation of Myostatin, c-Jun NH2-Terminal Kinase, Notch, and Akt Signaling Pathways.” Endocrinology, Feb. 2010; 151(2):628–638.
64.Moffat SD, Resnick SM. Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men.Neurobiol Aging. 2006 May 11
65.Gouras GK et al. Proc Natl Acad Sci U S A 2000 Feb 1; 97(3):1202-5
66.Tan RS. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male. 2003 Mar; 6(1):13-7.
67.Janowsky JS. Thinking with your gonads: testosterone and cognition. Trends Cogn Sci. 2006 Feb;10(2):77-82.
68.Holland J, Bandelow S, Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas. 2011;69:322-337.
69.O'Connor DB, Archer J, Hair WM, Wu FC. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men. Physiol Behav. 2002;75:557-566.
70.Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K. Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012 Aug 31.
71.Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011;8:3204-3213.
72.Somboonporn W., Davis S., Seif M.W. and Bell R. (2005). Testosterone for peri- and postmenopausal women. Cochrane Database of Systematic Reviews, Issue 4.
73.Rhoden EL, Averbeck MA. [Prostate carcinoma and testosterone: risks and controversies]. Arq Bras Endocrinol Metabol. 2009 Nov;53(8):956-62.
74.Cooper CS et al. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men J Urol 1998 Feb; 159(2):441-3
75.Morales A. Monitoring androgen replacement therapy: testosterone and prostate safety.J Endocrinol Invest. 2005; 28(3 Suppl):122-7
76.Prehn RT. On the prevention and therapy of prostate cancer by androgen administration. Cancer Res 1999 Sep 1; 59(17):4161-4
77.Morley JE. Testosterone replacement and the physiologic aspects of aging in men.Mayo Clin Proc. 2000 Jan; 75 Suppl: S83-7
78.Gould DC, Kirby RS Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?Prostate Cancer Prostatic Dis. 2006;9(1):14-8
79.Agarwal PK et al. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol. 2005 Feb; 173(2):533-6.
80.Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer. 2007 Feb 1;109(3):536-41
81.Morgentaler A et al. Testosterone therapy in men with untreated prostate cancer. Journal of Urology 2011 Apr;185(4)9.
82.Abramow M., Corvilain J.: Metabolic effects of human growth hormone in adults and children. J Ann Endocrinol (Paris) March-April 1963, 145-56.
83.Hernberg-Stahl E, Luger A, Abs R, Bengtsson BA, Feldt-Rasmussen U, Wilton P, Westberg B, Monson JP; KIMS International Board., KIMS Study Group. Pharmacia International Metabolic Database, "Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency," J Clin Endocrinol Metab. 2001 Nov;86(11):5277-81.
CONTRIBUTING PHYSICIANS & SCIENTISTS
Martin Dayton, D.O.; Medical Director, Dayton Medical Center (Florida, USA)
Robert M. Goldman, M.D., Ph.D., D.O.; Co-Founder & Chairman, American Academy of Anti-Aging Medicine; Co-Founder & Chairman, World Anti-Aging Academy of Medicine
Brad Grant D.O., past Pres., Osteopathic Physicians and Surgeons of California
James Forsythe, M.D., HMD; private practice (Nevada, USA)
Steven F. Hotze, M.D.; Director, Texas for Physicians’ and Patients’ Rights; Chief Executive Officer, Hotze Health & Wellness Center (Texas, USA)
Ronald M. Klatz, M.D., D.O.; Co-Founder & President, American Academy of Anti-Aging Medicine
Hans Kugler, Ph.D.; President & Founder, International Academy of Anti-Aging Medicine
A.Tina Miranda, M.D., MBA, private practice (Florida, USA)
Iris Breuer Mueller, M.D.; Psychiatrist, The Cantonal Hospital of Lucerne, Switzerland; University of Zurich, Switzerland
Emil K. Schandl, M.S., Ph.D., M.D., (MA), FNACB, SC(ASCP), CC(NRCC), LNC, CLD (FL, NY, CA); Director, American Metabolic Laboratories, Clinical Laboratory
C. Norman Shealy, M.D., Ph.D.; President, Holos Institutes of Health., Inc. (Missouri, USA)
Astrid Stuckelberger, MSc, Ph.D., Docent; Faculty of Medicine, University of Geneva, Switzerland; Secretary-General, International Association of Gerontology and Geriatrics – European Region; President, Geneva International Network on Aging; Expert on Aging at the United Nations and European Commission
ENDORSING ORGANIZATIONS
American Academy of Anti-Aging Medicine (A4M)
Academy of Anti-Aging Medicine - China
Asia-Oceania Federation of Anti-Aging Medicine (AOFAAM)
AustralAsian Academy of Anti-Aging Medicine
